WIRE — Polish pharma group Polpharma, which has bought the local drug producer Biofarm in a EUR257 million deal, has growth plans in Romania, a market it was not yet present on ahead of the acquisition.
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.